Literature DB >> 17530670

Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.

William J Taylor1, Kathryn M McPherson.   

Abstract

OBJECTIVE: Item-response theory is increasingly used in the development of robust measurement tools. The extent to which the Health Assessment Questionnaire (HAQ) disability index (DI) and Short Form 36 (SF-36) physical functioning subscale (PF) fit a Rasch model in psoriatic arthritis (PsA) is uncertain. Our objective was to compare the psychometric properties of the HAQ DI and SF-36 PF in PsA and rheumatoid arthritis (RA) using Rasch analysis.
METHODS: Patients with RA (n = 142) and PsA (n = 134) were identified from a disease register based at a regional rheumatology service that serves a population of approximately 400,000 individuals. Responses to the HAQ DI and SF-36 PF were analyzed for item fit, differential item functioning (DIF), scale length (item separation), floor effects, and item difficulty by fitting the data to a Rasch model. The extent to which each instrument measured the same concept (disability) was also assessed in the PsA cohort using the Rasch model.
RESULTS: Item separation was much better for the SF-36 PF than the HAQ DI in PsA (9.12 logits versus 2.06 logits). There was evidence of marked DIF for the HAQ DI items activities, grip, and rising and relatively minor DIF for 4 items of the SF-36 PF. The distribution of SF-36 PF was better than HAQ DI in PsA, with floor effects of 3.1% versus 30.4%. Common person equating demonstrated that the 2 instruments measure the same construct in PsA.
CONCLUSION: The SF-36 PF has significant psychometric advantages over the HAQ DI in PsA.

Entities:  

Mesh:

Year:  2007        PMID: 17530670     DOI: 10.1002/art.22770

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  Examining unidimensionality and improving reliability for the eight subscales of the SF-36 in opioid-dependent patients using Rasch analysis.

Authors:  Yu-Yu Hsiao; Ching-Lin Shih; Wan-Hui Yu; Cheng-Hsi Hsieh; Ching-Lin Hsieh
Journal:  Qual Life Res       Date:  2014-08-07       Impact factor: 4.147

2.  Greek adaptation and validation of the Ankylosing Spondylitis Quality of Life (ASQoL) measure.

Authors:  J E Graham; M Rouse; J Twiss; S P McKenna; A A Vidalis
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

Review 3.  Patient-Reported Outcomes in Psoriatic Arthritis.

Authors:  Ana-Maria Orbai; Alexis Ogdie
Journal:  Rheum Dis Clin North Am       Date:  2016-03-16       Impact factor: 2.670

4.  Adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire for use in Serbia.

Authors:  Mirjana Zlatkovic-Svenda; Matthew Rouse; Marija Radak-Perovic; Roksanda Stojanovic; Nada Vujasinovic-Stupar; Biljana Lazovic-Popovic; Jeanette Wilburn; Stephen P McKenna
Journal:  Rheumatol Int       Date:  2016-10-31       Impact factor: 2.631

5.  Effect of ethnicity on disease activity and physical function in psoriatic arthritis in a multiethnic Asian population.

Authors:  Ying Ying Leung; Warren Fong; Nai Lee Lui; Julian Thumboo
Journal:  Clin Rheumatol       Date:  2016-10-30       Impact factor: 2.980

6.  Application of the health assessment questionnaire disability index to various rheumatic diseases.

Authors:  Maaike M van Groen; Peter M ten Klooster; Erik Taal; Mart A F J van de Laar; Cees A W Glas
Journal:  Qual Life Res       Date:  2010-06-18       Impact factor: 4.147

7.  Testing whether patients with diabetes and healthy people perceive the meaning of the items in the Persian version of the SF-36 questionnaire similarly: a differential item functioning analysis.

Authors:  Zahra Bagheri; Peyman Jafari; Marzieh Mahmoodi; Mohammad Hossein Dabbaghmanesh
Journal:  Qual Life Res       Date:  2016-10-03       Impact factor: 4.147

8.  Testing measurement equivalence of the SF-36 questionnaire across patients on hemodialysis and healthy people.

Authors:  Zahra Bagheri; Peyman Jafari; Marjan Faghih; Elahe Allahyari; Tania Dehesh
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

9.  Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.

Authors:  J Twiss; S P McKenna
Journal:  Qual Life Res       Date:  2014-01-30       Impact factor: 4.147

10.  Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic Arthritis.

Authors:  Ying Ying Leung; Ana-Maria Orbai; Maarten de Wit; Andra Balanescu; Emmanuelle Dernis; Martin Soubrier; Lihi Eder; Josef S Smolen; Laura C Coates; Laure Gossec
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-03-13       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.